Table 1.
Clinical parameters of patients.
| Variables | Training cohort (n =90) | P | Validation cohort (n = 39) | P | ||
|---|---|---|---|---|---|---|
| ADC (n=61) | SCC (n=29) | ADC (n=26) | SCC (n=13) | |||
| Age (year) | 62.03 ± 9.06 | 66.27 ± 8.97 | 0.040 | 60.08 ± 9.96 | 63.62 ± 9.81 | 0.300 |
| Gender | <0.001* | 0.022* | ||||
| Male | 30 | 28 | 11 | 12 | ||
| Female | 31 | 1 | 15 | 1 | ||
| Smoking | <0.001* | 0.029* | ||||
| Never | 15 | 15 | 7 | 9 | ||
| Ever/Always | 46 | 10 | 19 | 4 | ||
| Spiculation | 0.004* | 0.307 | ||||
| Yes | 48 | 13 | 16 | 5 | ||
| No | 13 | 14 | 10 | 8 | ||
| lobulation | 0.930 | 0.397 | ||||
| Yes | 53 | 25 | 24 | 10 | ||
| No | 8 | 4 | 2 | 3 | ||
| null Vacuole | 0.628 | 0.687 | ||||
| Yes | 12 | 7 | 7 | 2 | ||
| No | 49 | 22 | 19 | 11 | ||
| tumor location | 0.030* | 0.687 | ||||
| Peripheral | 53 | 25 | 24 | 10 | ||
| Central | 8 | 4 | 2 | 3 | ||
| pleural effusion on the tumor side | 0.738 | 0.852 | ||||
| Yes | 5 | 3 | 2 | 2 | ||
| No | 56 | 26 | 24 | 11 | ||
| pericardial effusion | 0.274 | 0.608 | ||||
| Yes | 5 | 0 | 1 | 1 | ||
| No | 56 | 29 | 25 | 12 | ||
| distant metastasis | 0.016* | 0.420 | ||||
| Yes | 21 | 3 | 7 | 2 | ||
| No | 40 | 26 | 19 | 11 | ||
| CEA(ug/L) | 3.18 (1.76,9.90) |
2.60 (2.02,5.20) |
0.610 | 2.33 (1.63,5.50) |
3.28 (1.37,4.37) |
0.532 |
| NICAP | 0.09 (0.04,0.18) |
0.08 (0.01,0.14) |
0.223 | 0.12 (0.05,0.20) |
0.05 (0.03,0.12) |
0.136 |
| λHUAP | 1.39 ± 1.03 | 1.14 ± 1.02 | 0.267 | 1.86 ± 1.40 | 1.01 ± 0.65 | 0.044* |
| NICVP | 0.28 (0.16,0.46) |
0.19 (0.08,0.33) |
0.019* | 0.37 (0.21,0.47) |
0.17 (0.03,0.23) |
0.003* |
| λHUVP | 1.88 ± 1.07 | 1.21 ± 0.82 | 0.004* | 2.17 ± 1.13 | 0.96 ± 0.69 | 0.001* |
Data are the proportion of sample size, mean value ± SD or median (interquartile range). P values were the results of univariate analysis of each parameter, *p < 0.05.
AP, arterial phase; VP, venous phase.